
Work Here?
Raidium offers an AI-powered radiology platform that helps healthcare providers improve imaging biomarker characterization to support precision medicine. It learns from large unlabeled data using self-supervised learning and can handle multiple tasks across different imaging types because it is multimodal, processing text, images, and audio. Unlike many competitors, it emphasizes learning from unlabeled data and combines multimodal inputs with a focus on imaging biomarkers while pseudonymizing patient data to meet privacy rules. The goal is to make radiology departments more accurate and efficient worldwide, enabling faster and more reliable diagnoses for patients.
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
51-200
Company Stage
Seed
Total Funding
$20.1M
Headquarters
Roubaix, France
Founded
2022
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$20.1M
Above
Industry Average
Funded Over
2 Rounds
Industry standards
Remote Work Options
Raidium launches ai-native radiology platform across US cancer centers. What you should know. * AI-native radiology pioneer Raidium has announced the U.S. launch of its flagship platform, Raidium Read (R.Read), bringing agentic AI workflows directly to advanced oncology research institutions. * The company's system has been actively deployed at Moffitt Cancer Center, one of the nation's preeminent oncology facilities, where it successfully replaced the center's legacy radiomics applications. * Rejecting the standard approach of placing basic point solutions on top of obsolete interfaces, Raidium engineered an AI-native PACS viewer from the ground up to streamline tedious reading room tasks. * Leveraging its core foundation model, Curia, R.Read delivers organ-agnostic automated RECIST measurements across time points, cutting inter-reader variability by a factor of three. * Currently structured as a standalone pipeline for clinical trials and research environments, the platform features zero prerequisite backend integration hurdles, while formal FDA 510(k) clearances are projected before year-end 2026. The Curia foundation execution model. The architectural strategy driving Raidium moves entirely past the passivity of traditional imaging plugins to enforce a deeply integrated, context-aware environment. The system's backend intelligence is anchored by its proprietary foundation model, Curia, which has demonstrated state-of-the-art performance parameters across multi-modal imaging tasks. Operating from offices in Paris, France, and Silicon Valley, California, Raidium transforms the radiologist's dashboard into an interactive, promptable canvas. The platform streamlines the longitudinal lifecycle of oncology imaging through an automated execution loop: * Whole-Body Lesion Tracking: The system autonomously scans large-volume diagnostic inputs, executing high-fidelity lesion detection and segmentation across diverse anatomical regions. * Longitudinal Transfer Optimization: R.Read programmatically extracts historical lesion data from prior studies, mapping them against active follow-up imagery to eliminate manual search variables. * Automated RECIST Quantification: Leveraging foundation-level logic, the application performs organ-agnostic, automated Response Evaluation Criteria in Solid Tumors (RECIST) measurements across time points. * Variance Reduction Execution: By replacing manual, visual slide rules with structured, repeatable calculations, the engine decreases inter-reader variability by a full 3x. "For twenty years, the standard PACS viewers have resisted evolution, easily outmatched by the rigid limitations of early AI," stated Paul Herent, MD, CEO and Co-Founder of Raidium. "Today, however, agentic AI is driving a quiet revolution: a single, fluid convergence of everyday accessibility, conversational logic, and advanced reasoning that is finally poised to redefine the reading room. We are initially targeting oncology follow-up because no convincing AI solution has yet solved this complex workflow." Strategic value: streamlining the tumor board pipeline. The clinical necessity underlying Raidium's initial oncology focus is reinforced by changing clinical guidelines worldwide. Recent medical research demonstrates that early, precise lesion detection can successfully spare the majority of cancer patients from highly invasive surgical procedures. Concurrently, the World Health Organization is advancing aggressive new screening frameworks aimed at capturing precancerous lesions at an earlier, treatable stage. By consolidating these workflows within a single workspace, Raidium significantly eases the documentation burden on radiologists while maintaining full physician oversight. Dr. Cesar Lam, a radiologist in Moffitt Cancer Center's Diagnostic Imaging and Interventional Radiology Department, validated the operational shift: "Raidium's unified approach empowers us to explore research projects that would have seemed impossible not too long ago. It is transforming and empowering how we conduct oncology clinical research projects, giving our teams a tool designed for the complexity of real-world imaging data." Furthermore, by standardizing quantitative endpoints, the platform clarifies communication channels between radiologists and oncologists during high-stakes tumor boards, driving faster, data-backed medical decision-making.
Raidium has launched Raidium Read in the US, bringing its AI-powered imaging platform to cancer centres. The tool is designed to streamline oncology imaging workflows through whole-body lesion detection, AI segmentation, and longitudinal tracking across follow-up studies. Moffitt Cancer Center has already deployed the platform, replacing its legacy radiomics tool. The system aims to reduce manual effort and decrease inter-reader variability by three times whilst supporting complex oncology research. The platform is currently available for clinical trial and research use. Raidium is pursuing 510(k) clearance for certain features and expects regulatory approval before the end of 2026. Cancer centres can register for the platform at raidium.eu/viewer. Raidium combines foundation model research with a unified clinical viewer, keeping radiologists in control whilst automating workflows from indication to final report.
Introducing Jolia: its vision-language foundation model for CT. June 24, 2026 At Raidium, building toward AGI in radiology requires models that do more than see. They need to understand - to read a scan the way a radiologist does, connecting visual structure to clinical language. Today, Raidium is releasing Jolia, its vision-language foundation model for chest and abdominal CT, trained on paired scans and radiology reports. Alongside this release, Raidium is also introducing the Raidium model family: a named framework that describes how each layer of its technology - from foundation to application to clinical workflow - fits together. Jolia model evaluation at a glance. Jolia sets a new standard for vision-language AI in radiology. By combining global and concept-level image-text alignment, Jolia outperforms leading CT foundation models across findings classification, cross-center transfer, and report generation. * Jolia introduces ConQuer, a new pre-training method that augments global CLIP alignment with localized, per-concept alignments, one per anatomical region, learned end-to-end without any segmentation supervision * Jolia sets a new state-of-the-art on findings classification, outperforming all public baselines across chest and abdominal CT on both in-distribution and out-of-distribution benchmarks, including models trained on significantly larger private datasets * Jolia achieves the highest cross-center transfer performance, demonstrating robust generalization to unseen clinical institutions * Jolia leads on radiology report generation for abdominal CT, with a +34% relative gain on RadGraph-F1 over the previous best model and the highest clinical fidelity score across all evaluated systems The Raidium model family. Raidium models are organized across three tiers. At the foundation sit RadSAM, Curia, and Jolia. RadSAM is its original segmentation foundation model, generalizing anatomy segmentation. Curia is its vision-only foundation model family, trained on over 200 million CT and MRI slices to build deep structural understanding across modalities. Jolia is its vision-language family - trained on paired scans and radiology reports to align imaging and clinical text. Above the foundation sit its application models: RaidiumSeg for segmentation, RaidiumDetect for lesion detection, and RaidiumProp for longitudinal propagation across timepoints. RaidiumFlow orchestrates these into coherent workflows. At the top sit its clinical workflows. OncoPilot brings detection, segmentation, longitudinal tracking, and structured reporting into a single experience for oncology radiologists. One platform. One foundation. Each layer built on the one below. I. Why vision-language alignment matters. Curia and Curia-2 demonstrated the power of scale: pre-training on vast, unlabeled CT and MRI slices produces a model that generalizes across anatomy, modality, and disease in ways task-specific architectures cannot. But structural understanding alone has limits. The clinical value of a finding depends on being able to name it, describe it, and communicate it - tasks that require connecting imaging to language. Jolia is trained to make that connection. Pre-trained on chest and abdominal CT paired with radiology reports, Jolia learns to map what it sees in the volume to the clinical concepts radiologists use to describe it. This enables classification of findings across 171 abnormalities, structured report generation, and representations that transfer reliably across centers - all from a single foundation model. II. The challenge: structure lost in translation. The standard approach to vision-language pre-training, CLIP-style alignment, compresses both the entire image and report into single global vectors and learns to match them. This works well for natural images with short captions. It is a poor fit for radiology. A CT scan of the chest and abdomen spans dozens of organs. A radiological report describes findings organ by organ - liver, lungs, kidneys, lymph nodes - in structured sections that are much longer and richer than a typical caption. Encoding all of this into one global token inevitably loses detail. An observation about the liver can be overwhelmed by the rest of the report. A focal lesion in a single lobe can be averaged out. Recent approaches have tried to recover this structure using segmentation masks, explicitly cropping organs before alignment. This works, but at a cost: it limits coverage to the organs a segmentation tool supports, and it adds a dependency on expensive spatial supervision. III. ConQuer: concept-level alignment without spatial supervision. Jolia is trained using ConQuer (Concept Queries), a new image-text pre-training method Raidium developed to address this gap. ConQuer augments standard global CLIP alignment with a parallel set of localized alignments - one per anatomical concept. On the text side, Raidium use an LLM to split each radiology report into concept-specific sections, grouping findings by organ. On the image side, Raidium introduce a small set of learnable cross-attention queries - one per concept - that pool concept-specific features directly from the image encoder, with no segmentation mask or spatial annotation required. Each query learns where to attend purely through the per-concept contrastive loss: it is trained to match the image features for its concept (e.g., liver) against the text describing that concept across patients in the batch. As a byproduct, these queries produce attention maps that are anatomically coherent and interpretable - the model learns to look at the liver when reading about the liver, without ever being told where the liver is. Jolia uses 102 anatomical concepts spanning chest and abdominal CT, and is pre-trained on 74,434 public CT-report pairs. IV. Results: state of the art across the board. Findings classification. Jolia sets a new state-of-the-art on findings classification across both chest and abdominal CT, evaluated on four datasets covering 252 abnormalities in- and out-of-distribution. Against its in-house CLIP baseline (same encoders, global alignment only), Jolia gains +1.7 AUROC on average, with the largest gains on out-of-distribution test sets. Against the strongest public baselines, Jolia outperforms Pillar-0 by +2.2 AUROC on CT-RATE and beats SPECTRE by +2.0 AUROC on external abdominal CT - while also surpassing segmentation-based methods that rely on organ-level masks, by up to +9.4 AUROC on chest. Crucially, per-concept tokens add consistent value beyond the global [CLS] representation, and the combination of both is best on every evaluated configuration. Cross-Center transfer. Medical AI models are routinely tested at the center they were trained on - and routinely fail when deployed elsewhere. Jolia is designed to transfer. Trained on public chest and abdominal CT datasets, it achieves the highest cross-center transfer performance on both external evaluation sets: 77.05% average AUROC on out-of-distribution data, outperforming all baselines including models trained on significantly larger private corpora. The ConQuer loss adds +2.7 AUROC on average over the global CLIP baseline in the transfer setting - the largest gains concentrated on the hardest, out-of-distribution splits. Radiology report generation. Raidium fine-tuned Jolia's encoder with a Qwen3.5-9B language model to generate the findings section of abdominal CT reports from the volume alone. Jolia achieves state-of-the-art performance on the Merlin-Abd-CT benchmark, leading on four of six clinical metrics including a +34% relative gain on RadGraph-F1 over Merlin, and the highest GREEN score across all evaluated models. V. Looking ahead. Jolia is the first member of a family of vision-language models. The next steps are clear: scaling to larger and more diverse data, extending to new modalities and anatomical regions, and continuing to improve the ConQuer methodology - including jointly training the text encoder and scaling the concept taxonomy beyond anatomy. Within the Raidium platform, the structural backbone provided by Curia already powers its application and workflow layers. Jolia opens the next chapter: by aligning imaging and clinical language, it creates the foundation for a findings applied model - translating what the model sees in a scan into structured, clinically precise observations. More on how this comes together soon. Ready to explore Jolia? Acknowledgements. Thank you to its partners CIN, IDRIS and GENCI.
We are pleased to announce that our Fund has recently added Raidium, a seed-stage company specializing in precision radiology, to our portfolio. Raidium
Debiopharm Innovation Fund has added Raidium, a seed-stage company specializing in precision radiology, to its portfolio. Raidium is developing a radiological multimodal foundation model, enhancing diagnostic accuracy and efficiency. Their AI-biomarker API aids clinical trials by improving and creating new biomarkers. This investment will help Raidium deploy its prototype to market and expand its team, supporting more industrial and academic biomarker research projects.
Find jobs on Simplify and start your career today
Industries
Data & Analytics
Enterprise Software
AI & Machine Learning
Healthcare
Company Size
51-200
Company Stage
Seed
Total Funding
$20.1M
Headquarters
Roubaix, France
Founded
2022
Find jobs on Simplify and start your career today